Fig. 2From: Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective studyGraft survival rate for renal transplant recipients receiving induction therapy with rATG or IL2-RABack to article page